Just in time for summer, the U.S. Food and Drug Administration (FDA) announced game-changing news. The FDA expanded the emergency use authorization for the Pfizer messenger RNA Covid-19 vaccine for kids ages 12–15 years old.
The Pfizer-BioNTech Covid-19 vaccine met the FDA’s safety and efficacy criteria to expand the emergency use authorization. Until now, the Pfizer vaccine was approved for use in people 16 years and older.
Pfizer previously announced in a press release highly encouraging results from their phase 3 clinical trial. The Pfizer-BioNTech Covid-19 vaccine was 100% effective and generated a high antibody response in children ages 12–15.